Used primarily in pharmaceutical research as an intermediate in the synthesis of antipsychotic agents. Its structure supports the development of compounds targeting central nervous system disorders, particularly schizophrenia and other dopamine-related conditions. The molecule’s phenothiazine core contributes to receptor binding properties, while the piperazine and chlorophenyl groups enhance pharmacokinetic behavior, making it valuable in optimizing drug candidates for improved efficacy and stability.